Who Owns IGC Pharma Stock?
NYSE: IGCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 22.09%
- Held by insiders
- 13.17%
- Institutional holders
- 40
- Institutions 22.1%
- Insiders 13.2%
- Public and other 64.7%
Who owns IGC Pharma stock?
Institutional investors own about 22.1% of IGC Pharma's shares, spread across 40 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 13.17% of IGC.
The largest institutional holders are Geode Capital Management, LLC (2.22%), Vanguard Capital Management LLC (2.06%) and Blackrock Inc. (1.78%). Together, the top 10 institutions control 11.9% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their IGC positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IGC
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Geode Capital Management, LLC | 879.39K | 2.22% | -15.7% |
| Vanguard Capital Management LLC | 814.91K | 2.06% | +13.4% |
| Blackrock Inc. | 703.80K | 1.78% | 0.0% |
| AdvisorShares Investments, LLC | 678.48K | 1.71% | +100.0% |
| Citadel Advisors Llc | 437.32K | 1.10% | +100.0% |
| Vanguard Fiduciary Trust Co | 419.41K | 1.06% | +0.8% |
| Renaissance Technologies, LLC | 286.61K | 0.72% | -40.8% |
| State Street Corporation | 200.80K | 0.51% | 0.0% |
| Northern Trust Corporation | 170.27K | 0.43% | +50.1% |
| DEARBORN PARTNERS LLC | 118.80K | 0.30% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IGC
| Fund | Shares | % Held |
|---|---|---|
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | 939.48K | 2.37% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 814.91K | 2.06% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 464.26K | 1.17% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 98.55K | 0.25% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 95.37K | 0.24% |
Frequently asked questions
Who is the largest shareholder of IGC Pharma?
Geode Capital Management, LLC is the largest institutional shareholder of IGC, owning 2.22% of shares outstanding (879.39K shares) as of its latest 13F filing.
What percentage of IGC Pharma is owned by institutions?
Institutions own about 22.1% of IGC shares and 25.4% of the public float.
How much of IGC Pharma do insiders own?
Insiders, such as officers and directors, own about 13.17% of IGC shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.